{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:21Z","timestamp":1791409881048,"version":"4.3.3"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110262","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:02:20Z","timestamp":1784934140000},"page":"110262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrative drug repositioning identifies FDA-approved inhibitors of HSP90AA1 with therapeutic potential in colorectal cancer"],"prefix":"10.1016","volume":"181","author":[{"given":"Xuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110262_bb0005","series-title":"Global cancer Burden Growing, Amidst Mounting Need for Services","author":"W.H. Organization","year":"2024"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110262_bb0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","article-title":"Is early-onset cancer an emerging global epidemic? Current evidence and future implications","volume":"19","author":"Ugai","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110262_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7136","article-title":"The death burden of colorectal cancer attributable to modifiable risk factors, trend analysis from 1990 to 2019 and future predictions","volume":"13","author":"Zhu","year":"2024","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110262_bb0025","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2026.110262_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ans.18142","article-title":"Immunotherapy in colorectal cancer: a beacon of hope","volume":"93","author":"Mui","year":"2023","journal-title":"ANZ J. Surg."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ajco.13552","article-title":"Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis","volume":"18","author":"Nindra","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110262_bb0040","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2004.11.037","article-title":"Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment","volume":"22","author":"Grothey","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110262_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1541-7786.MCR-06-0404","article-title":"The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents","volume":"5","author":"Tabernero","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43094-020-00047-9","article-title":"Exploring different approaches to improve the success of drug discovery and development projects: a review","volume":"6","author":"Kiriiri","year":"2020","journal-title":"Future J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110262_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","article-title":"The high price of anticancer drugs: origins, implications, barriers, solutions","volume":"14","author":"Prasad","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110262_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcdb.2016.08.033","article-title":"Colorectal cancer heterogeneity and targeted therapy: clinical implications, challenges and solutions for treatment resistance","volume":"64","author":"Zhai","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110262_bb0065","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"14","key":"10.1016\/j.bioorg.2026.110262_bb0070","article-title":"Applications of artificial intelligence in drug repurposing","volume":"12","author":"Wan","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110262_bb0080","series-title":"Drug Selectivity: An Evolving Concept in Medicinal Chemistry","first-page":"79","article-title":"Discovery technologies for drug repurposing","author":"Issa","year":"2017"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bcp.14964","article-title":"Repurposing existing therapeutics, its importance in oncology drug development: kinases as a potential target","volume":"88","author":"Islam","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110262_bb0090","first-page":"220","article-title":"Thymidylate synthase: a critical target for cancer chemotherapy","volume":"1","author":"Rose","year":"2002","journal-title":"Clin. Colorectal Cancer"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110262_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/omi.2019.0151","article-title":"Rethinking drug repositioning and development with artificial intelligence, machine learning, and omics","volume":"23","author":"Koromina","year":"2019","journal-title":"OMICS"},{"issue":"205","key":"10.1016\/j.bioorg.2026.110262_bb0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006667","article-title":"High-throughput methods for combinatorial drug discovery","volume":"5","author":"Sun","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110262_bb0105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/toxics12110822","article-title":"Recent advances in omics, computational models, and advanced screening methods for drug safety and efficacy","volume":"12","author":"Son","year":"2024","journal-title":"Toxics"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110262_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad142","article-title":"Decoding connectivity map-based drug repurposing for oncotherapy","volume":"24","author":"Zhao","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110262_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.487","article-title":"Getting started with LINCS datasets and tools","volume":"2","author":"Xie","year":"2022","journal-title":"Curr. Protoc."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12967-023-04056-z","article-title":"Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model","volume":"21","author":"Tan","year":"2023","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110262_bb0125","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1007\/s12035-024-04124-5","article-title":"Transcriptomics of human brain tissue in Parkinson's disease: a comparison of bulk and single-cell RNA sequencing","volume":"61","author":"Fiorini","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12859-022-04662-6","article-title":"Computationally repurposing drugs for breast cancer subtypes using a network-based approach","volume":"23","author":"Firoozbakht","year":"2022","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bioorg.2026.110262_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2020.11.056","article-title":"Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses","volume":"19","author":"Li","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41467-023-36637-3","article-title":"ASGARD is a single-cell guided pipeline to aid repurposing of drugs","volume":"14","author":"He","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110262_bb0150","series-title":"Statistical Genomics: Methods and Protocols","first-page":"93","article-title":"The gene expression omnibus database","author":"Clough","year":"2016"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2105-8-22","article-title":"Gene network interconnectedness and the generalized topological overlap measure","volume":"8","author":"Yip","year":"2007","journal-title":"BMC Bioinf."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110262_bb0160","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/bioinformatics\/btt269","article-title":"CMAP: complement map database","volume":"29","author":"Yang","year":"2013","journal-title":"Bioinformatics"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110262_bb0165","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/bioinformatics\/btab404","article-title":"Interfacing Seurat with the R tidy universe","volume":"37","author":"Mangiola","year":"2021","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110262_bb0170","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1158\/2159-8290.CD-22-1467","article-title":"Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression","volume":"13","author":"Hsu","year":"2023","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110262_bb0175","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110262_bb0180","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/wics.147","article-title":"ggplot2","volume":"3","author":"Wickham","year":"2011","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110262_bb0195","series-title":"Amber 2024","author":"Case","year":"2024"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0200","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/bcr1996","article-title":"NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models","volume":"10","author":"Jensen","year":"2008","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110262_bb0205","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chembiol.2004.03.033","article-title":"Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms","volume":"11","author":"Wright","year":"2004","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theory Comput."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110262_bb0215","doi-asserted-by":"crossref","DOI":"10.1063\/5.0019056","article-title":"A fast and high-quality charge model for the next generation general AMBER force field","volume":"153","author":"He","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110262_bb0220","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110262_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","article-title":"From tumour heterogeneity to advances in precision treatment of colorectal cancer","volume":"14","author":"Punt","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PPO.0000000000000638","article-title":"Gene expression profiles in cancers and their therapeutic implications","volume":"29","author":"Creighton","year":"2023","journal-title":"Cancer J."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110262_bb0235","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"10.1016\/j.bioorg.2026.110262_bb0240","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: the evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110262_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.790952","article-title":"A database of drug repurposing clinical trials in oncology","volume":"12","author":"Pantziarka","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110262_bb0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41416-023-02502-9","article-title":"Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy","volume":"130","author":"Weth","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13321-020-00450-7","article-title":"A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions","volume":"12","author":"Jarada","year":"2020","journal-title":"J. Cheminform."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0260","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10142-024-01356-5","article-title":"Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data","volume":"24","author":"Zhao","year":"2024","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.bioorg.2026.110262_bb0265","series-title":"Recent Understanding of Colorectal Cancer Treatment","first-page":"9","article-title":"Utilising proteomics and organoid cultures for predicting treatment response in colorectal cancer","author":"Micallef","year":"2022"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110262_bb0270","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ctrv.2006.07.001","article-title":"Irinotecan in the treatment of colorectal cancer","volume":"32","author":"Fuchs","year":"2006","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0275","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1535-7163.MCT-08-0534","article-title":"Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models","volume":"8","author":"Pitts","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110262_bb0280","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2001.19.5.1501","article-title":"Irinotecan in the treatment of colorectal cancer: clinical overview","volume":"19","author":"Vanhoefer","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0285","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s13402-023-00882-x","article-title":"Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer","volume":"47","author":"Finnegan","year":"2024","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bioorg.2026.110262_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115212","article-title":"Anticancer clinical efficiency and stochastic mechanisms of belinostat","volume":"165","author":"El Omari","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110262_bb0295","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41416-022-01892-6","article-title":"Modulation of autophagy: a phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)","volume":"127","author":"Arora","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110262_bb0300","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/17843286.2017.1302623","article-title":"The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib","volume":"72","author":"Engur","year":"2017","journal-title":"Acta Clin. Belg."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110262_bb0305","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1093\/jn\/130.11.2718","article-title":"Biomarkers of human colonic cell growth are influenced differently by a history of colonic neoplasia and the consumption of acarbose","volume":"130","author":"Weaver","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.bioorg.2026.110262_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115951","article-title":"Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer","volume":"440","author":"Asgharzadeh","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110262_bb0315","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1007\/s11033-022-07262-y","article-title":"Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8(+) T-cell mediated cytotoxicity in colorectal cancer","volume":"49","author":"Dong","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110262_bb0320","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1002\/jcp.29580","article-title":"(curcumin+sildenafil) enhances the efficacy of 5FU and anti-PD1 therapies in vivo","volume":"235","author":"Dent","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110262_bb0325","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/mc.20752","article-title":"Nifedipine synergizes with calcium in activating the calcium sensing receptor, suppressing the expression of thymidylate synthase and survivin and promoting sensitivity to fluorouracil in human colon carcinoma cells","volume":"50","author":"Liu","year":"2011","journal-title":"Mol. Carcinog."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110262_bb0330","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1080\/07391102.2018.1489305","article-title":"In vitro cytotoxicity and DNA\/HSA interaction study of triamterene using molecular modelling and multi-spectroscopic methods","volume":"37","author":"Moghadam","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110262_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271602","article-title":"In-silico investigations of quinine and quinidine as potential inhibitors of AKR1B1 and AKR1B10: functional and structural characterization","volume":"17","author":"Ejaz","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2026.110262_bb0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.intimp.2016.04.014","article-title":"Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage","volume":"36","author":"Amini-Khoei","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2026.110262_bb0345","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphar.2017.00103","article-title":"Estrone Sulfate transport and steroid sulfatase activity in colorectal Cancer: implications for hormone replacement therapy","volume":"8","author":"Gilligan","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110262_bb0350","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/bbrc.2000.2444","article-title":"Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein","volume":"270","author":"Arai","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-2999(90)94064-5","article-title":"Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles","volume":"186","author":"Cesura","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110262_bb0360","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jemermed.2024.09.013","article-title":"Promethazine: a review of therapeutic uses and toxicity","volume":"70","author":"Le","year":"2025","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.bioorg.2026.110262_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1512469","article-title":"Mitochondria: a crucial factor in the progression and drug resistance of colorectal cancer","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.110262_bb0370","article-title":"Advances in research on the relationship between mitochondrial function and colorectal cancer: a bibliometric study from 2013 to 2023","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0375","doi-asserted-by":"crossref","first-page":"24494","DOI":"10.1038\/s41598-021-03569-1","article-title":"Determination of tyrosinase-cyanidin-3-O-glucoside and (\u2212\/+)-catechin binding modes reveal mechanistic differences in tyrosinase inhibition","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110262_bb0380","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1038\/s41598-021-89627-0","article-title":"Drug repurposing for ligand-induced rearrangement of Sirt2 active site-based inhibitors via molecular modeling and quantum mechanics calculations","volume":"11","author":"Bharadwaj","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110262_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125825","article-title":"Natural antiretroviral compounds as the inhibitors of the SARS-CoV-2 M protein","volume":"412","author":"Negi","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.110262_bb0390","doi-asserted-by":"crossref","first-page":"129255","DOI":"10.1016\/j.molliq.2026.129255","article-title":"A comparative computational study of the action of various anticonvulsant drugs upon monomeric form of bacterial sodium channel (NavMs), homolog of human voltage-gated sodium channels","volume":"446","author":"Yadava","year":"2026","journal-title":"J. Mol. Liq."},{"issue":"10 Pt A","key":"10.1016\/j.bioorg.2026.110262_bb0395","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.bbamcr.2015.05.012","article-title":"Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer","volume":"1853","author":"Su","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110262_bb0400","first-page":"207","article-title":"Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer","volume":"13","author":"Cercek","year":"2014","journal-title":"Clin. Colorectal Cancer"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:08:41Z","timestamp":1791407321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"alternative-id":["S0045206826007984"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110262","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative drug repositioning identifies FDA-approved inhibitors of HSP90AA1 with therapeutic potential in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110262"}}